Photo by wildpixel/iStock / Getty Images

Active Studies include

Alzheimer’s can be so difficult. Caring for a loved one with Alzheimer’s disease is a heavy lift. And when agitation is a factor, it’s all the more difficult. Dealing with the erratic, aggressive behavior on top of the heartbreaking memory loss can become exhausting. But as a caregiver, you are far from alone. More than 15 million Americans provide unpaid care for people with Alzheimer’s and other dementias. And over a five year study, agitation and aggression were seen in approximately 45% of Alzheimer’s disease patients.


If your loved one has been diagnosed with Alzheimer’s disease and is experiencing agitation symptoms, the ADVANCE Study may be an option.

See if your loved one may qualify - Contact our office (732) 244-2299

The ADVANCE Study is recruiting seniors 65 to 90 years of age who have been diagnosed with Alzheimer’s disease and are experiencing agitation symptoms to take part in a clinical research study. The purpose of the study is to determine the safety and effectiveness of an investigational medication for agitation in patients with Alzheimer’s disease.

Individuals will be evaluated to determine their eligibility to participate in the study. If eligible, study participants will receive the study drug (AXS-05), an active control (bupropion), or a placebo control (inactive substance) orally as a tablet taken twice daily for five consecutive weeks. All three products look identical, but only AXS-05 contains the active drug intended to treat your loved one’s agitation. Study participants will also receive study-related medical exams and laboratory tests at no cost. Compensation for time and travel may also be available.

Parkinson’s Disease with Depression

50% of Parkinson’s patients suffer from some form of depression. Have you been on an antidepressant in the past or are you currently taking antidepressant medication and still experiencing feelings of sadness, hopelessness, difficulty concentrating , difficulty sleeping? Your past or current medication alone may not be effective. Learn about a clinical research study an investigational drug, pimavanserin, that may help with these symptoms. Study related visits, laboratory work and medication are at no cost.

To qualify for these treatment trials, we encourage you to contact us by email or by calling us at (732) 244-2299. 

Alzheimer’s with Agitation

Agitation can hide in the shadows of Alzheimer’s. If you have a loved one with Alxheimer’s disease who has shown signs of agitation, you may want to learn more about this research study of an investigational drug. To pre-qualify for this study patients must be:

  • Be between 55 and 90 yeas of age.

  • Have been diagnosed with Alzheimer’s disease

  • Have a diagnosis of agitation

All study related visits, tests and drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided.

Otsuka Alzheimer’s with Agitation 331

Call us for more information, or to schedule a free evaluation.